Literature DB >> 27836054

Clinical Phenotypes of Hyper-IgM Syndromes.

M Teresa de la Morena1.   

Abstract

The primary immunodeficiency (PID) diseases comprise a heterogeneous group of inherited disorders of immune function. Technical advancements in whole-genome, whole-exome, and RNA-sequencing have seen the explosion of genetic discoveries in the field of PIDs. The present review aims to focus on a group of immunodeficiency disorders associated with elevated levels of IgM (hyper IgM; HIGM) and provides a clinical differential diagnosis. Most patients present for evaluation of immunodeficiency due to recurrent infections, and laboratory studies show either a clear isolated elevation of serum immunoglobulin M (IgM) with low or absent IgG, IgA, and IgE. Alternatively, IgM levels may be normal or moderately elevated while other serum immunoglobulins are reported below the norms for age but not absent. Mechanistically, these disorders are recognized as defects in immunoglobulin (Ig) class switch recombination (CSR). Importantly, to safeguard genetic stability, CSR utilizes elements of the DNA repair machinery including multi-protein complexes involved in mismatch repair (MMR). Therefore, it is not uncommon for defects in the DNA repair machinery, to present with laboratory findings of HIGM. This review will discuss clinical phenotypes associated with congenital defects associated with HIGM. Clinical manifestations, relevant immunologic testing, inheritance pattern, molecular diagnosis, presumed pathogenesis, and OMIM number, when annotated are compiled. Accepted therapeutic options, when available, are reviewed for each condition discussed.
Copyright © 2016 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Class switch recombination defects; HIGM; Hyper-IgM syndrome; XHIGM

Mesh:

Substances:

Year:  2016        PMID: 27836054     DOI: 10.1016/j.jaip.2016.09.013

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  25 in total

1.  Respiratory Complications in Patients with Hyper IgM Syndrome.

Authors:  Bobak Moazzami; Reza Yazdani; Gholamreza Azizi; Fatemeh Kiaei; Mitra Tafakori; Mohammadreza Modaresi; Rohola Shirzadi; Seyed Alireza Mahdaviani; Mahsa Sohani; Hassan Abolhassani; Asghar Aghamohammadi
Journal:  J Clin Immunol       Date:  2019-06-11       Impact factor: 8.317

2.  A Novel Mutation in CD40LG Gene Causing X-Linked Hyper IgM Syndrome.

Authors:  Hyung Young Kim; Tae Min Um; Hee Ju Park
Journal:  Indian J Pediatr       Date:  2017-12-15       Impact factor: 1.967

3.  X-linked hyper-IgM syndrome complicated with interstitial pneumonia and liver injury: a new mutation locus in the CD40LG gene.

Authors:  Tian-Jiao Wang; Li-Fang Wu; Junguo Chen; Wen Zhu; Hua Wang; Xiao-Lin Liu; Yi-Qun Teng
Journal:  Immunol Res       Date:  2019-10       Impact factor: 2.829

4.  Clinical and molecular features of X-linked hyper IgM syndrome - An experience from North India.

Authors:  Amit Rawat; Babu Mathew; Vignesh Pandiarajan; Ankur Jindal; Madhubala Sharma; Deepti Suri; Anju Gupta; Shubham Goel; Adil Karim; Biman Saikia; Ranjana W Minz; Kohsuke Imai; Shigeaki Nonoyama; Osamu Ohara; Silvia Clara Giliani; Luigi D Notarangelo; Koon-Wing Chan; Yu-Lung Lau; Surjit Singh
Journal:  Clin Immunol       Date:  2018-07-25       Impact factor: 3.969

5.  Primary Immunodeficiency: New Insights and Practical Clinical Approaches.

Authors:  Charlotte Cunningham-Rundles
Journal:  J Allergy Clin Immunol Pract       Date:  2016 Nov - Dec

6.  CD40 Ligand Deficiency in Latin America: Clinical, Immunological, and Genetic Characteristics.

Authors:  Tábata Takahashi França; Lucila Akune Barreiros; Ranieri Coelho Salgado; Sarah Maria da Silva Napoleão; Lillian Nunes Gomes; Janáira Fernandes Severo Ferreira; Carolina Prando; Cristina Worm Weber; Regina Sumiko Watanabe Di Gesu; Cecilia Montenegro; Carolina Sanchez Aranda; Gisele Kuntze; Aidé Tamara Staines-Boone; Edna Venegas-Montoya; Juan Carlos Aldave Becerra; Liliana Bezrodnik; Daniela Di Giovanni; Ileana Moreira; Gisela Analia Seminario; Andrea Cecilia Gómez Raccio; Mayra de Barros Dorna; Nelson Augusto Rosário-Filho; Herberto Jose Chong-Neto; Elisa de Carvalho; Milena Baptistella Grotta; Julio Cesar Orellana; Miguel Garcia Dominguez; Oscar Porras; Laura Sasia; Karina Salvucci; Emilio Garip; Luiz Fernando Bacarini Leite; Wilma Carvalho Neves Forte; Fernanda Pinto-Mariz; Ekaterini Goudouris; María Enriqueta Nuñez Nuñez; Magdalena Schelotto; Laura Berrón Ruiz; Diana Inés Liberatore; Hans D Ochs; Otavio Cabral-Marques; Antonio Condino-Neto
Journal:  J Clin Immunol       Date:  2022-01-04       Impact factor: 8.317

Review 7.  Cellular and Molecular Defects Underlying Invasive Fungal Infections-Revelations from Endemic Mycoses.

Authors:  Pamela P Lee; Yu-Lung Lau
Journal:  Front Immunol       Date:  2017-06-28       Impact factor: 7.561

Review 8.  Molecular basis and therapeutic implications of CD40/CD40L immune checkpoint.

Authors:  TingTing Tang; Xiang Cheng; Billy Truong; LiZhe Sun; XiaoFeng Yang; Hong Wang
Journal:  Pharmacol Ther       Date:  2020-10-20       Impact factor: 12.310

9.  A delayed diagnosis of X-linked hyper IgM syndrome complicated with toxoplasmic encephalitis in a child: A case report and literature review.

Authors:  Xiaoliang Liu; Kaiyu Zhou; Dan Yu; Xiaotang Cai; Yimin Hua; Hui Zhou; Chuan Wang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

10.  Elevated IgM levels as a marker for a unique phenotype in patients with Ataxia telangiectasia.

Authors:  Alexander Krauthammer; Avishay Lahad; Lior Goldberg; Ifat Sarouk; Batia Weiss; Raz Somech; Michalle Soudack; Itai M Pessach
Journal:  BMC Pediatr       Date:  2018-06-04       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.